<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/55D85F5D-EB2A-4BE6-A76F-54B480468B1A"><gtr:id>55D85F5D-EB2A-4BE6-A76F-54B480468B1A</gtr:id><gtr:name>Department of Clinical Neurosciences</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/76B9E34F-0CE7-44BC-A9AA-B08CFBDF4FD2"><gtr:id>76B9E34F-0CE7-44BC-A9AA-B08CFBDF4FD2</gtr:id><gtr:name>Society of British Neurological Surgeons</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E76C7F07-63A8-4C65-918D-F4FE5A2E4F83"><gtr:id>E76C7F07-63A8-4C65-918D-F4FE5A2E4F83</gtr:id><gtr:name>European Brain Injury Consortium (EBIC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C1FFEA46-9B1E-4484-B889-23D42E20092E"><gtr:id>C1FFEA46-9B1E-4484-B889-23D42E20092E</gtr:id><gtr:name>International Neurotrauma Society (INTS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Neurosurgery</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/55D85F5D-EB2A-4BE6-A76F-54B480468B1A"><gtr:id>55D85F5D-EB2A-4BE6-A76F-54B480468B1A</gtr:id><gtr:name>Department of Clinical Neurosciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/76B9E34F-0CE7-44BC-A9AA-B08CFBDF4FD2"><gtr:id>76B9E34F-0CE7-44BC-A9AA-B08CFBDF4FD2</gtr:id><gtr:name>Society of British Neurological Surgeons</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E76C7F07-63A8-4C65-918D-F4FE5A2E4F83"><gtr:id>E76C7F07-63A8-4C65-918D-F4FE5A2E4F83</gtr:id><gtr:name>European Brain Injury Consortium (EBIC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C1FFEA46-9B1E-4484-B889-23D42E20092E"><gtr:id>C1FFEA46-9B1E-4484-B889-23D42E20092E</gtr:id><gtr:name>International Neurotrauma Society (INTS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/ABCBB528-7405-4626-86A0-B43F95164F37"><gtr:id>ABCBB528-7405-4626-86A0-B43F95164F37</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Hutchinson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A0B920BC-8E87-4628-975D-709A1BB7ED7D"><gtr:id>A0B920BC-8E87-4628-975D-709A1BB7ED7D</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Murphy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C828AB5C-9C0A-4D67-B4D1-2DF46085991E"><gtr:id>C828AB5C-9C0A-4D67-B4D1-2DF46085991E</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Krishna</gtr:otherNames><gtr:surname>Menon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B7296B44-D98A-4E67-8053-E7E99D157D05"><gtr:id>B7296B44-D98A-4E67-8053-E7E99D157D05</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Douglas</gtr:otherNames><gtr:surname>Pickard</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/FA7D42FC-6FAD-486F-B8EB-5F5FA4DE9BD2"><gtr:id>FA7D42FC-6FAD-486F-B8EB-5F5FA4DE9BD2</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:otherNames>Adrian</gtr:otherNames><gtr:surname>Carpenter</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/84721CE0-7564-4EEC-82E0-A098F6431088"><gtr:id>84721CE0-7564-4EEC-82E0-A098F6431088</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Grice</gtr:surname><gtr:orcidId>0000-0003-4658-4534</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B20C33A9-70A2-460F-AA99-01292E88FF97"><gtr:id>B20C33A9-70A2-460F-AA99-01292E88FF97</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:surname>Gallagher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/02904723-E7E3-4F86-89FE-0CA15D44C46A"><gtr:id>02904723-E7E3-4F86-89FE-0CA15D44C46A</gtr:id><gtr:firstName>Adel</gtr:firstName><gtr:otherNames>Ezzat</gtr:otherNames><gtr:surname>Helmy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5A8DCBFD-FF2F-415E-926F-9BFB42C9A8EA"><gtr:id>5A8DCBFD-FF2F-415E-926F-9BFB42C9A8EA</gtr:id><gtr:firstName>Keri</gtr:firstName><gtr:surname>Carpenter</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1002277"><gtr:id>51C71824-317F-4D18-BF56-03EE184B2E06</gtr:id><gtr:title>Cerebral Energy Metabolism in Injured and Uninjured Brain</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1002277</gtr:grantReference><gtr:abstractText>Head Injury is the largest single cause of death in those aged under 45 years in the developed world. After the initial trauma, a number of processes can cause further damage to the brain. One of these factors is the inability of nerve cells (neurones) to make enough energy. This study investigates how neurones use different fuels after head injury, and how this differs from normal brain and other tissues such as muscle. By using a technique called microdialysis we can deliver different brain fuels (glucose, pyruvate, succinate) and track how the brain uses them by tagging each fuel with a form of heavy carbon (C13). We can also use a specialised form of MRI scan called phosphorus MR spectrocopy to measure how much energy is stored in the cells as a molecule called ATP. A better understanding of how the brain makes energy when it is injured can allow us to develop treatments for a variety of conditions including head injury.</gtr:abstractText><gtr:technicalSummary>This study aims to investigate derangements in cerebral energy metabolism following traumatic brain injury. While the concept of energy failure is well recognised as a mechanism of neuronal injury and ultimately poor clinical outcome, the specific abnormalities compared with normal metabolism remain unclear. We propose delivering specific 13C labelled substrates to the human brain following trauma using microdialysis, to sequentially interrogate the glycolytic pathway (glucose supplementation), the tricarboxcylic acid cycle (pyruvate supplementation) and oxidative phosphorylation (succinate supplementation). We will monitor the metabolic consequences using a combination of (1) microdialysis parameters (including the lactate/pyruvate ratio to determine the redox state of the cell), (2) high-resolution Nuclear Magnetic Resonance spectroscopy of the microdialysates to analyse the downstream metabolites and determine the positions of 13C-labelling within these molecules (to ascertain which biochemical pathways are functioning), and (3) in vivo 31P Magnetic Resonance Spectroscopy to assess energy status (phosphocreatine/inorganic phosphate ratio and phosphocreatine/adenosine triphosphate ratio) at a cellular level. In order to differentiate the consequences of injury from normal metabolism, we will carry out parallel microdialysis studies in uninjured human brain and muscle. Together, these studies will increase our understanding of metabolic impairment in the injured brain and determine whether supplementation of specific substrates can improve energy generation as a potential therapeutic avenue. This may ultimately lead to novel strategies to improve clinical outcome.</gtr:technicalSummary><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>408036</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Society of British Neurological Surgeons</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>British Neurosurgical Trainee Research Collaborative</gtr:description><gtr:id>0B32AA40-C9E8-40D0-98BE-9C8144C84582</gtr:id><gtr:impact>PMID: 22583319</gtr:impact><gtr:partnerContribution>The SBNS has very generously supported this initiative since its inception.</gtr:partnerContribution><gtr:piContribution>AK and PH led the efforts to establish the British Neurosurgical Trainee Research Collaborative. The BNTRC is a research network for trainees which will aim to develop, run and support neurosurgical trials.</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Clinical Neurosciences</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Division of Neurosurgery</gtr:department><gtr:description>13C-labelled microdialysis</gtr:description><gtr:id>B048E381-9174-4294-89D3-F5675DC916EE</gtr:id><gtr:impact>Publication: Gallagher CN, Carpenter KL, Grice P, Howe DJ, Mason A, Timofeev I, Menon DK, Kirkpatrick PJ, Pickard JD, Sutherland GR, Hutchinson PJ. The human brain utilizes lactate via the tricarboxylic acid cycle: a 13C-labelled microdialysis and high-resolution nuclear magnetic resonance study. Brain. 2009 Oct;132(Pt 10):2839-2849. PubMed PMID: 19700417.</gtr:impact><gtr:partnerContribution>Our collaborator has visited us in Cambridge on a Visiting Fellowship (awarded by the Canadian Institute of Health Research). The collaboration is ongoing and our collaborator is a Co-investigator on a current MRC Research Grant (PI: Peter Hutchinson, G1002277 ID 98489).</gtr:partnerContribution><gtr:piContribution>13C labelling studies of brain metabolism using microdialysis in traumatic brain injury patients.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Society of British Neurological Surgeons</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>International Multicentre Randomised Trial</gtr:description><gtr:id>5940C88D-49C7-4C8B-AA61-0AD0552B50AD</gtr:id><gtr:impact>Recruitment of 280 patients from 43 centres in 17 countries</gtr:impact><gtr:partnerContribution>Patient recruitment</gtr:partnerContribution><gtr:piContribution>Study set-up, patient recruitment and data collection</gtr:piContribution><gtr:sector>Learned Society</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Brain Injury Consortium (EBIC)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>International Multicentre Randomised Trial</gtr:description><gtr:id>849A0733-93BE-476F-B427-CD1C003C5707</gtr:id><gtr:impact>Recruitment of 280 patients from 43 centres in 17 countries</gtr:impact><gtr:partnerContribution>Patient recruitment</gtr:partnerContribution><gtr:piContribution>Study set-up, patient recruitment and data collection</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Neurotrauma Society (INTS)</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:description>International Multicentre Randomised Trial</gtr:description><gtr:id>755D3F0B-7963-44C2-B140-C49EB40337C1</gtr:id><gtr:impact>Recruitment of 280 patients from 43 centres in 17 countries</gtr:impact><gtr:partnerContribution>Patient recruitment</gtr:partnerContribution><gtr:piContribution>Study set-up, patient recruitment and data collection</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Engineering</gtr:department><gtr:description>Engineering - finite element analysis of decompressive craniectomy</gtr:description><gtr:id>7C19CDC9-5737-40EC-A4B7-5236D7EFDB71</gtr:id><gtr:impact>Publications</gtr:impact><gtr:partnerContribution>Finite element analysis of decompressive craniectomy</gtr:partnerContribution><gtr:piContribution>Increasing the understanding of the clinical consequences of brain deformation after craniectomy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Society of British Neurological Surgeons</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>British Neurotrauma Group</gtr:description><gtr:id>4B10FAFA-61E6-42FA-9E7A-ED62EA1A0E9C</gtr:id><gtr:impact>The first academic meeting of the group took place in 2010 (October). The meeting was attended by neurosurgeons, neurorehabilitation consultants, endocrinologists, neurologists and specialist nurses.</gtr:impact><gtr:partnerContribution>Increasing understanding of the issues surrounding decompressive craniectomy in head injury</gtr:partnerContribution><gtr:piContribution>Initiative to set up a special-interest group within the Society of British Neurological Surgeons</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Science Festival Presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2BC7FDF7-4254-4C89-A0E5-F366A86BB82A</gtr:id><gtr:impact>Cambridge Science Festival</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Science Festival,</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6B38F03D-752C-4B6E-865F-7D261FDC6F96</gtr:id><gtr:impact>Talk given at the British Science Festival, Newcastle, September 2013.

This activity generated interest in our studies on head-injured patients.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Publication of patient's journey after a head injury with patient as the first author</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4390030A-BB78-403E-B4D4-352B78CB5531</gtr:id><gtr:impact>This paper which described the journey after a head injury from the patient's perspective will allow healthcare professionals to understand the challenges brain-injured patients face.

The paper has been tweeted a few times on Twitter</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://europepmc.org/abstract/MED/24737905</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media RESCUEicp results</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>10358BCD-133B-4DB7-B456-4CEFBD3DBEAE</gtr:id><gtr:impact>Dissemination of the RESCUEicp results published in the BMJ</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>617000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>NIHR Health Technology Assessment Grant- Risk adjustment in Neurocritical care (RAIN)</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>C63DA58B-C5D3-4EFE-8859-430DFEF2E09F</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2016 Addenbrooke's Charitable Trust Grant for Seahorse analyser to measure energy metabolism at a cellular level &amp;pound;25k</gtr:description><gtr:fundingOrg>Addenbrooke's Charitable Trust (ACT)</gtr:fundingOrg><gtr:id>5402F999-3919-4ECD-8120-153385B41E88</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>29000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>2013 EU collaborative grant CENTER-TBI [Prospective longitudinal data collection and Comparative Effectiveness Research (CER) for traumatic brain injury (TBI)] Start 1st October 2013. 78 months Total Euro 29,998,903 University of Cambridge Euro 2,840,158</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>51D29F55-E267-433D-970B-B3A08D835E3E</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Collaborative Grant for Acute Brain Injury</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0600986</gtr:fundingRef><gtr:id>56236F79-30E0-4C2F-A776-FC5782A54650</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>968031</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>2017 ERA NET International Collaboration On Neuroinflammation in Traumatic Brain Injury (ICON-TBI) Euro 968031 (co-investigator)</gtr:description><gtr:fundingOrg>ERA-NET ANIHWA</gtr:fundingOrg><gtr:id>50F88F06-2213-4A9B-A94B-71F765033F10</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Brain Injury HTC</gtr:department><gtr:description>2017 NIHR HTC Grant for Gadolinium microdialysis Multimodality Monitoring &amp;pound;5k start March 2017 (lead applicant and chief investigator)</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>C5624A81-E28D-4A6D-9232-883FA6C7024E</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1237656</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>2014 NIHR Research Professorship. Start 1st January 2014 5 years &amp;pound;1,237,656</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>7048F118-737B-4940-9ADC-A4582FFFF536</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Evidence based planning solution for TBI</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>FDA6CB8A-247B-4239-8949-CD596F347878</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1260000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>Cambridge BRC - Clinical Neurosciences Component (PI Head Injury Research)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>CA6469F3-7306-426B-9C01-DB09E1BC0B7F</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>536627</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR i4i Invention for Innovation (i4i) Programme</gtr:department><gtr:description>2016 NIHR i4i Development of microdialysis online sensor technology for use in critical care of acute brain trauma patients &amp;pound;536,627 start 1st October 2016 for 3 years (PI)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>AA46C064-D864-4F1C-9B04-AF9580CE57F9</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>2013 NIHR HTC Grant- Brain Injury. Start 1st January 2013 4 years &amp;pound;800,000 (co-applicant)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>408E38BD-0799-4AE9-8915-A41F8EB4C131</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48375</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Research Grant</gtr:department><gtr:description>MRC Confidence in Concepts</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0EA5465B-DC87-4DDA-9D68-0852B1BB3AF2</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>MRI compatible device to transmit monitoring probes into the brain.</gtr:description><gtr:id>A1CA9D49-46AF-4D29-9F0C-BD7E12D6CB0E</gtr:id><gtr:impact>Use in clinical practice</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:patentId>9822006.4</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Cranial access device</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Multidisciplinary consensus conference on Multimodality Monitoring in Neurocritical Care</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5DCE97F7-5A64-427F-B3F8-FBB015B78C1C</gtr:id><gtr:impact>Consensus statement is expected to act as a catalyst for improving management of brain-injured patients.</gtr:impact><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://link.springer.com/article/10.1007/s12028-014-0041-5</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>2014 Cambridge International Microdialysis Forum, St Catharine's College</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>61B2D85C-4C21-44CE-9C9B-C5C72FF2A8A3</gtr:id><gtr:impact>Update consensus statement for the application of clinical microdialysis</gtr:impact><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Consensus conference of intracranial pressure monitoring in traumatic brain injury</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>BE574DAD-CBC0-474D-B135-1660C15A2598</gtr:id><gtr:impact>The consensus meeting output is expected to consolidate the place of ICP monitoring in the management of brain-injured patients</gtr:impact><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://link.springer.com/article/10.1007/s00701-014-2127-4</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Neurosurgical Representative on the current NICE Committee revising the NICE guidelines for the early management of head injury in adults and children (due to be published published in 2013/4)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CCF358B7-DC40-4DFD-9454-4822293AC016</gtr:id><gtr:impact>Head injury guidelines</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Brain chemistry sensor</gtr:description><gtr:id>F3C75149-5063-4F3F-910F-425F8EBE74EA</gtr:id><gtr:impact>On-going</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>New Chemistry Sensor</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Outcome from traumatic brain injury in the UK.</gtr:description><gtr:id>98F52031-F6C9-4EEC-8F9A-CE505731D12A</gtr:id><gtr:impact>Availability of head injury outcome data in the open access literature.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Contribution to TARN</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Application of PCA to micro dialysis</gtr:description><gtr:id>E379E1E2-2391-468C-8D42-6BA34F33FB27</gtr:id><gtr:impact>Improved understanding of the neuro-inflammatory response to head injury</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Principle Component Analysis</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>ICU monitoring software. Developed by Marek Czosnyka and Peter Smielewski.</gtr:description><gtr:id>A3FC1FD2-36AE-4702-9C03-11BB407CCAFB</gtr:id><gtr:impact>Take up internationally</gtr:impact><gtr:title>ICMplus</gtr:title><gtr:type>Software</gtr:type></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>ICMplus - Cambridge Enterprise. Led by Marek Czosnyka and Peter Smielewski.</gtr:companyName><gtr:description>Medical software,</gtr:description><gtr:id>809EAB8B-AB17-4B0B-87AA-9C31375AB954</gtr:id><gtr:impact>Improvement of monitoring and data capture in Intensive Care.</gtr:impact></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A4298EBA-C64F-49CC-8FA3-E2CEE26F8F7C"><gtr:id>A4298EBA-C64F-49CC-8FA3-E2CEE26F8F7C</gtr:id><gtr:title>Glycolysis and the significance of lactate in traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1662-453X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/78AD6972-CA20-4FE7-88DD-8000AC437256"><gtr:id>78AD6972-CA20-4FE7-88DD-8000AC437256</gtr:id><gtr:title>Lactate uptake by the injured human brain: evidence from an arteriovenous gradient and cerebral microdialysis study.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5540FE1B-3B9C-4938-808F-BE7D1E2D5500"><gtr:id>5540FE1B-3B9C-4938-808F-BE7D1E2D5500</gtr:id><gtr:title>(13)C-labelled microdialysis studies of cerebral metabolism in TBI patients.</gtr:title><gtr:parentPublicationTitle>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0928-0987</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1EC1F3E9-1532-4F04-8307-09903CD38672"><gtr:id>1EC1F3E9-1532-4F04-8307-09903CD38672</gtr:id><gtr:title>Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de49ceeeba6bbdb0d7189a130938fe75"><gtr:id>de49ceeeba6bbdb0d7189a130938fe75</gtr:id><gtr:otherNames>Guilfoyle MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32E41F00-54FE-49A6-971C-DA78757F80C5"><gtr:id>32E41F00-54FE-49A6-971C-DA78757F80C5</gtr:id><gtr:title>A microdialysis study of oral vigabatrin administration in head injury patients: preliminary evaluation of multimodality monitoring.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica. Supplement</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-1419</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0534F4A2-B658-4CC8-BF7D-54A295F64D94"><gtr:id>0534F4A2-B658-4CC8-BF7D-54A295F64D94</gtr:id><gtr:title>International multidisciplinary consensus conference on multimodality monitoring: cerebral metabolism.</gtr:title><gtr:parentPublicationTitle>Neurocritical care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1f0008da45fff319bdc0d58930b8bca2"><gtr:id>1f0008da45fff319bdc0d58930b8bca2</gtr:id><gtr:otherNames>Hutchinson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1541-6933</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/00D3D7A5-C22C-4E71-AA19-5EA3FDC4CDD7"><gtr:id>00D3D7A5-C22C-4E71-AA19-5EA3FDC4CDD7</gtr:id><gtr:title>Lactate uptake by the injured human brain: evidence from an arteriovenous gradient and cerebral microdialysis study.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0D262F8E-D560-4163-930D-608359704585"><gtr:id>0D262F8E-D560-4163-930D-608359704585</gtr:id><gtr:title>A microdialysis study of oral vigabatrin administration in head injury patients: preliminary evaluation of multimodality monitoring.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica. Supplement</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-1419</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A941232-171F-43EA-A8FD-679EE9CEF71A"><gtr:id>0A941232-171F-43EA-A8FD-679EE9CEF71A</gtr:id><gtr:title>Monitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0482ab6c0e91e5b3cbf602ea6fad1642"><gtr:id>0482ab6c0e91e5b3cbf602ea6fad1642</gtr:id><gtr:otherNames>Shannon RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/48275AB3-6A73-4E40-962A-24A0CC0E8193"><gtr:id>48275AB3-6A73-4E40-962A-24A0CC0E8193</gtr:id><gtr:title>Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings.</gtr:title><gtr:parentPublicationTitle>Metabolic brain disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0885-7490</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/678F1F3B-4E95-490A-B45A-37518AA8C7AA"><gtr:id>678F1F3B-4E95-490A-B45A-37518AA8C7AA</gtr:id><gtr:title>Extracellular N-Acetylaspartate in Human Traumatic Brain Injury.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0482ab6c0e91e5b3cbf602ea6fad1642"><gtr:id>0482ab6c0e91e5b3cbf602ea6fad1642</gtr:id><gtr:otherNames>Shannon RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/78C96990-7D86-4DC1-8699-70B21836C1B8"><gtr:id>78C96990-7D86-4DC1-8699-70B21836C1B8</gtr:id><gtr:title>Principal component analysis of the cytokine and chemokine response to human traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/516AFED3-ABC8-4FFF-A4B1-A60688BAC8F0"><gtr:id>516AFED3-ABC8-4FFF-A4B1-A60688BAC8F0</gtr:id><gtr:title>Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications.</gtr:title><gtr:parentPublicationTitle>Journal of pharmacokinetics and pharmacodynamics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0482ab6c0e91e5b3cbf602ea6fad1642"><gtr:id>0482ab6c0e91e5b3cbf602ea6fad1642</gtr:id><gtr:otherNames>Shannon RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1567-567X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CFDFB1E-ED96-4129-A16C-9C0318537F9F"><gtr:id>5CFDFB1E-ED96-4129-A16C-9C0318537F9F</gtr:id><gtr:title>Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F46EE85C-80A5-425F-943A-D96F07EF0F7B"><gtr:id>F46EE85C-80A5-425F-943A-D96F07EF0F7B</gtr:id><gtr:title>Consensus statement from the 2014 International Microdialysis Forum.</gtr:title><gtr:parentPublicationTitle>Intensive care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/783c2d727ee166ac861102bdf24a11b1"><gtr:id>783c2d727ee166ac861102bdf24a11b1</gtr:id><gtr:otherNames>Hutchinson PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0342-4642</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E2861D4-A0A8-46E9-A9DB-2E44B06182CA"><gtr:id>3E2861D4-A0A8-46E9-A9DB-2E44B06182CA</gtr:id><gtr:title>Neurotrauma - a multidisciplinary disease.</gtr:title><gtr:parentPublicationTitle>International journal of clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05e1ef8c32a3763e23ffa82f0f4f375c"><gtr:id>05e1ef8c32a3763e23ffa82f0f4f375c</gtr:id><gtr:otherNames>Wilson MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1368-5031</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/00A433CD-AFE8-4BC5-9A89-B1D721BF58C0"><gtr:id>00A433CD-AFE8-4BC5-9A89-B1D721BF58C0</gtr:id><gtr:title>Extracellular brain pH with or without hypoxia is a marker of profound metabolic derangement and increased mortality after traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6cec6ebabac01f3aa33da0058c420a30"><gtr:id>6cec6ebabac01f3aa33da0058c420a30</gtr:id><gtr:otherNames>Timofeev I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36D280B5-92EC-42E6-B467-4207D0CFC945"><gtr:id>36D280B5-92EC-42E6-B467-4207D0CFC945</gtr:id><gtr:title>Systemic, local, and imaging biomarkers of brain injury: more needed, and better use of those already established?</gtr:title><gtr:parentPublicationTitle>Frontiers in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-2295</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E6AABDB-D53B-4C6D-9BDE-CF3D3BB51857"><gtr:id>2E6AABDB-D53B-4C6D-9BDE-CF3D3BB51857</gtr:id><gtr:title>Predicting the outcome for individual patients with traumatic brain injury: a case-based review.</gtr:title><gtr:parentPublicationTitle>British journal of neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbe761dc965908c16150bcd5fde1f592"><gtr:id>fbe761dc965908c16150bcd5fde1f592</gtr:id><gtr:otherNames>Carter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0268-8697</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0BEAFC2B-E508-417D-9CA8-3BAAC784255B"><gtr:id>0BEAFC2B-E508-417D-9CA8-3BAAC784255B</gtr:id><gtr:title>Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.</gtr:title><gtr:parentPublicationTitle>Neurocritical care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db9e225390ac2fdabc60e616c2b60704"><gtr:id>db9e225390ac2fdabc60e616c2b60704</gtr:id><gtr:otherNames>Le Roux P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1541-6933</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7934A221-69E5-4E2F-BBEC-AF6F17DE03C7"><gtr:id>7934A221-69E5-4E2F-BBEC-AF6F17DE03C7</gtr:id><gtr:title>The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Journal of neuroinflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ced39d1f99179e5ffe5edc968b042a67"><gtr:id>ced39d1f99179e5ffe5edc968b042a67</gtr:id><gtr:otherNames>Singh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-2094</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BEA3AA01-AC50-460F-93BC-0D40E886AB9B"><gtr:id>BEA3AA01-AC50-460F-93BC-0D40E886AB9B</gtr:id><gtr:title>Glycolysis and the significance of lactate in traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1662-453X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42A2B8D3-B87B-4C24-9C54-62ED53291BB9"><gtr:id>42A2B8D3-B87B-4C24-9C54-62ED53291BB9</gtr:id><gtr:title>Systemic, local, and imaging biomarkers of brain injury: more needed, and better use of those already established?</gtr:title><gtr:parentPublicationTitle>Frontiers in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-2295</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6CDE9830-6514-47DF-A0BA-27CB417B57A9"><gtr:id>6CDE9830-6514-47DF-A0BA-27CB417B57A9</gtr:id><gtr:title>Clinical and Physiological Events That Contribute to the Success Rate of Finding &amp;quot;Optimal&amp;quot; Cerebral Perfusion Pressure in Severe Brain Trauma Patients.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/29cd57850a9f79a95e555d08b4f23697"><gtr:id>29cd57850a9f79a95e555d08b4f23697</gtr:id><gtr:otherNames>Weersink CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D3A5157-5FC7-41CB-BFDC-D806C97AC152"><gtr:id>1D3A5157-5FC7-41CB-BFDC-D806C97AC152</gtr:id><gtr:title>Glycolysis and the pentose phosphate pathway after human traumatic brain injury: microdialysis studies using 1,2-(13)C2 glucose.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA0BC5EE-E0B5-493E-936D-3341A3204470"><gtr:id>CA0BC5EE-E0B5-493E-936D-3341A3204470</gtr:id><gtr:title>Traumatic brain injury in England and Wales: prospective audit of epidemiology, complications and standardised mortality.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9840fd94b2f1df7980e154fd24bf3379"><gtr:id>9840fd94b2f1df7980e154fd24bf3379</gtr:id><gtr:otherNames>Lawrence T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1EA1FBA4-9704-431A-AD63-CF352F4BE7A8"><gtr:id>1EA1FBA4-9704-431A-AD63-CF352F4BE7A8</gtr:id><gtr:title>Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings.</gtr:title><gtr:parentPublicationTitle>Metabolic brain disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0885-7490</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E7999E9-E41C-4888-BE91-E1FFF9F18A90"><gtr:id>1E7999E9-E41C-4888-BE91-E1FFF9F18A90</gtr:id><gtr:title>Just what is going on in his head: a patient's journey after a severe traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fed4776b19d3a493339dfff578f911f8"><gtr:id>fed4776b19d3a493339dfff578f911f8</gtr:id><gtr:otherNames>Piercy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5757219-7DCE-4408-82E5-0388C96756D2"><gtr:id>C5757219-7DCE-4408-82E5-0388C96756D2</gtr:id><gtr:title>Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/274bdf7aacaeaabedd6556fa74b07bf9"><gtr:id>274bdf7aacaeaabedd6556fa74b07bf9</gtr:id><gtr:otherNames>Hong YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D6A82E14-A539-4482-B2D1-DF61EAB9B8A8"><gtr:id>D6A82E14-A539-4482-B2D1-DF61EAB9B8A8</gtr:id><gtr:title>Dynamic Changes in White Matter Abnormalities Correlate With Late Improvement and Deterioration Following TBI: A Diffusion Tensor Imaging Study.</gtr:title><gtr:parentPublicationTitle>Neurorehabilitation and neural repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/01930f5080ff9e680c6182997b91c811"><gtr:id>01930f5080ff9e680c6182997b91c811</gtr:id><gtr:otherNames>Newcombe VF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1545-9683</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8AC6BFE5-9244-463D-9171-00BF52D23EAB"><gtr:id>8AC6BFE5-9244-463D-9171-00BF52D23EAB</gtr:id><gtr:title>Focally perfused succinate potentiates brain metabolism in head injury patients.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6F883415-2F19-414B-BD0E-D3EA67B1490C"><gtr:id>6F883415-2F19-414B-BD0E-D3EA67B1490C</gtr:id><gtr:title>Increased blood glucose is related to disturbed cerebrovascular pressure reactivity after traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Neurocritical care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b5253df76357f3cea34383ed014c8f2"><gtr:id>0b5253df76357f3cea34383ed014c8f2</gtr:id><gtr:otherNames>Donnelly J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1541-6933</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53FF0ACA-AAA2-489A-A578-AB2EEB9136FF"><gtr:id>53FF0ACA-AAA2-489A-A578-AB2EEB9136FF</gtr:id><gtr:title>Glycolysis and the pentose phosphate pathway after human traumatic brain injury: microdialysis studies using 1,2-(13)C2 glucose.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4574D8EC-827F-4FD4-BE54-FFF7E5618421"><gtr:id>4574D8EC-827F-4FD4-BE54-FFF7E5618421</gtr:id><gtr:title>Extracellular N-Acetylaspartate in Human Traumatic Brain Injury.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0482ab6c0e91e5b3cbf602ea6fad1642"><gtr:id>0482ab6c0e91e5b3cbf602ea6fad1642</gtr:id><gtr:otherNames>Shannon RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB1D1392-04C5-4F77-B102-CCF2C8B4AB2D"><gtr:id>EB1D1392-04C5-4F77-B102-CCF2C8B4AB2D</gtr:id><gtr:title>Clinical applications of intracranial pressure monitoring in traumatic brain injury : report of the Milan consensus conference.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d6fd993e201b0bf7cde036886ae07816"><gtr:id>d6fd993e201b0bf7cde036886ae07816</gtr:id><gtr:otherNames>Stocchetti N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06A3A474-C355-4890-BA84-D409D79E9A17"><gtr:id>06A3A474-C355-4890-BA84-D409D79E9A17</gtr:id><gtr:title>Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2DC26C4-705C-40F1-9F61-38B2A5554AEB"><gtr:id>E2DC26C4-705C-40F1-9F61-38B2A5554AEB</gtr:id><gtr:title>(13)C-labelled microdialysis studies of cerebral metabolism in TBI patients.</gtr:title><gtr:parentPublicationTitle>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0928-0987</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/08A18C1D-4A2E-4572-806C-F3D6BDBE3600"><gtr:id>08A18C1D-4A2E-4572-806C-F3D6BDBE3600</gtr:id><gtr:title>Response to letter &amp;quot;Lactate uptake against a concentration gradient: misinterpretation of analytical imprecision&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002277</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>